Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery

Tam, Moses; Narayana, Ashwatha; Raza, Shahzad; Kunnakkat, Saroj; Golfinos, John; Parker, Erik; Novik, Yelena
February 2014
Medical Oncology;Feb2014, Vol. 31 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Treatment of Brain Metastasis from Lung Cancer. Chi, Alexander; Komaki, Ritsuko // Cancers;2010, Vol. 2 Issue 4, p2100 

    Brain metastases are not only the most common intracranial neoplasm in adults but also very prevalent in patients with lung cancer. Patients have been grouped into different classes based on the presence of prognostic factors such as control of the primary tumor, functional performance status,...

  • Progress in the Biological Understanding and Management of Breast Cancer-Associated Central Nervous System Metastases. Dawood, Shaheenah; Gonzalez‐Angulo, Ana M. // Oncologist;Jun2013, Vol. 18 Issue 6, p675 

    Metastasis to the central nervous system (CNS) is a devastating neurological complication of systemic cancer. Brain metastases from breast cancer have been documented to occur in approximately10%-16%of cases over the natural course of the disease with leptomeningeal metastases occurring in...

  • Miscellaneous.  // Current Medical Literature: Kidney Cancer;Sep2010, Vol. 2 Issue 3, p95 

    The article presents a study on radiotherapy of brain metastasized with renal cell cancer (RCC). It reports on whole-brain radiotherapy (WBRT), stereotactic radiosurgery (SRS) and surgery as treatment options for brain metastasis from RCC. Authors of the study concluded that SRS is a better and...

  • Breast cancer brain metastases: the last frontier. Leone, José Pablo; Leone, Bernardo Amadeo // Experimental Hematology & Oncology;11/24/2015, Vol. 4, p1 

    Breast cancer is a common cause of brain metastases, with metastases occurring in at least 10-16 % of patients. Longer survival of patients with metastatic breast cancer and the use of better imaging techniques are associated with an increased incidence of brain metastases. Unfortunately,...

  • Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer. Tallet, Agnes V.; Azria, David; Le Rhun, Emilie; Barlesi, Fabrice; Carpentier, Antoine F.; Gonçalves, Antony; Taillibert, Sophie; Dhermain, Frédéric; Spano, Jean-Philippe; Metellus, Philippe // International Journal of Molecular Sciences;May2014, Vol. 15 Issue 5, p8138 

    Breast cancer is the second most common cause of brain metastases and deserves particular attention in relation to current prolonged survival of patients with metastatic disease. Advances in both systemic therapies and brain local treatments (surgery and stereotactic radiosurgery) have led to a...

  • The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Walbert, Tobias; Gilbert, Mark R. // International Journal of Clinical Oncology;Aug2009, Vol. 14 Issue 4, p299 

    Brain metastases are the most frequent cancer in the central nervous system, being ten times more common than primary brain tumors. Patients generally have a poor outcome with a median survival of 4 months after diagnosis of the metastases. Therapeutic options include surgery, stereotactic,...

  • Brain Metastases: Contemporary Management and Future Directions. Husain, Zain A.; Regine, William F.; Kwok, Young; Feigenberg, Steven J. // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 3, p38 

    Brain metastases are a common cause of morbidity and mortality in cancer patients. Proper patient selection can help identify patients likely to benefit from aggressive treatment of their brain metastases. We will review these factors, as well as the role of different treatment modalities...

  • CNS Complications of Breast Cancer: Current and Emerging Treatment Options. Kaal, Evert C. A.; Vecht, Charles J. // CNS Drugs;2007, Vol. 21 Issue 7, p559 

    In general, the development of CNS metastases of breast cancer depends on several prognostic factors, including younger age and a negative hormone receptor status. Also, the presence of a breast cancer 1, early onset (BRCA1) germline mutation and expression of the human epidermal growth factor...

  • Breast cancer brain metastases: new directions in systemic therapy. Lin, Nancy U. // Ecancermedicalscience;2013, Vol. 7, p1 

    The management of patients with brain metastases from breast cancer continues to be a major clinical challenge. The standard initial therapeutic approach depends upon the size, location, and number of metastatic lesions and includes consideration of surgical resection, whole-brain radiotherapy,...

  • Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes? Byeong-Bae Park; Ji Uhm; Eun Cho; Yoon Choi; Sang Ji; Do Nam; Jung Lee; Won Park; Seung Huh; Yeon Park; Jin Ahn; Young-Hyuck Im // Cancer Chemotherapy & Pharmacology;Mar2009, Vol. 63 Issue 4, p627 

    We conducted this study to analyze clinicopathologic features and treatment outcomes for various treatment modalities in breast cancer patients with brain metastases. Retrospective analysis was performed using medical records of patients who were diagnosed with metastatic brain tumors from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics